Harald Enzmann

Medicine · Health Sciences

23h-index1.8kcitations137works13.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Allergic Rhinitis and Sensitization(18), Health Systems, Economic Evaluations, Quality of Life(12), Contact Dermatitis and Allergies(11), Carcinogens and Genotoxicity Assessment(9), Sinusitis and nasal conditions(9)

Publications137 total

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop
The Lancet Oncology·2025· 13 citedOpen Access
The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors
The Oncologist·2023· 1 citedOpen Access
Ein schwerer Verlust - nicht nur für die Allergologie
Allergo Journal·2023
P04.03 Cancer immunotherapies, companion diagnostics and precision medicine
Poster presentations·2022Open Access
Attention for sex in COVID-19 trials: a review of regulatory dossiers
BMJ Global Health·2022· 9 citedOpen Access
The Rat Liver Hepatocellular-Altered, Focus-Limited Bioassay for Chemicals with Carcinogenic Activity
2021· 2 cited
The European Medicines Agency Review of Luspatercept for the Treatment of Adult Patients With Transfusion-dependent Anemia Caused by Low-risk Myelodysplastic Syndromes With Ring Sideroblasts or Beta-thalassemia
HemaSphere·2021· 9 citedOpen Access
EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma
The Oncologist·2021· 4 citedOpen Access
The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease
HemaSphere·2021· 7 citedOpen Access
The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutation
ESMO Open·2021· 11 citedOpen Access
The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer
ESMO Open·2021· 41 citedOpen Access
The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusions and adult patients with non-small-cell lung cancer harbouring ROS1 rearrangements
ESMO Open·2021· 26 citedOpen Access
The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer
ESMO Open·2021· 17 citedOpen Access
EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia
The Oncologist·2021· 12 citedOpen Access
The EMA assessment of encorafenib in combination with cetuximab for the treatment of adult patients with metastatic colorectal carcinoma harbouring the BRAFV600E mutation who have received prior therapy
ESMO Open·2021· 15 citedOpen Access
The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitors
ESMO Open·2021· 5 citedOpen Access
The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
The Lancet·2021· 101 citedOpen Access
EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma
The Oncologist·2020· 45 citedOpen Access
EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma
The Oncologist·2020· 6 citedOpen Access
Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?
Clinical Pharmacology & Therapeutics·2020· 33 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Francesco Pignatti(12), Peter Bannasch(8), Julio Delgado(8), Christian Gisselbrecht(5), Michael J. Iatropoulos(5), Gary M. Williams(5), Ashish Shukla(3), Doris Mayer(3), H. Zwierzina(3), Hans‐Georg Eichler(3), Spiros Vamvakas(3), Guido Rasi(3), Kyriaki Tzogani(3), Blanca Garcia-Ochoa(3), Dagmar Ohlhauser(3), Thomas Dettler(3), Jorge Camarero(3), Marco Cavaleri(2), Lothar Bergmann(2), Bruno Sepodes(2)